Pharma Pulse: FDA Shifts CAR-T Standards and Maryland Expands Medical Class Size, as Pharma Channels Brace for Massive Patent Cliff Disruption

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.

• First, let’s turn to the evolving regulatory landscape for cutting-edge therapies. The FDA has outlined a new path for personalized treatments, including CAR-T. Recognizing the challenges of traditional randomized trials for these small, specialized populations, the agency described how it will be requiring potential CAR-T therapies to demonstrate superiority over existing CAR-Ts through a control group in randomized controlled clinical trials.
• Next, we look at the personnel challenge facing the entire healthcare system. Amid growing national concerns about physician shortages—projected to hit up to 84,000 by 2036—the University of Maryland School of Medicine is taking action. The school has received approval to gradually increase its entering class size from 175 to 200 students by 2031. This step highlights the critical infrastructure investment needed to secure the future physician workforce and ensure patient access to care across primary and specialty services.
• Lastly, the commercial channel is bracing for a wave of financial disruption. Commercialization expert Bill Roth recently underscored the critical need for "adaptive capacity" across the industry. This is driven by accelerating government regulation, like the Inflation Reduction Act, and a combined $380 billion patent cliff looming over general medicine and specialty markets. To survive, companies can no longer rely on single strategies; they must implement flexible models that span traditional distribution.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.